Active Filter(s):
Details:
Acquisition of Sera Labs will add to CURE a growing brand portfolio and monetization platform that fits remarkably well with CURE’s development capabilities, products, and existing market verticals.
Lead Product(s): Cannabidiol,Aspartame
Therapeutic Area: Dermatology Product Name: Seratopical
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: CURE Pharmaceutical
Deal Size: $44.0 million Upfront Cash: $20.0 million
Deal Type: Acquisition July 28, 2020